Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combivent vs Albuterol in Moderate to Severe Asthma
NCT00096616Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2004
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ipratropium bromide and salbutamol in asthma (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: FEV1 Area Under the Curve 0 to 6 hours and Peak Forced Expiratory Volume in 1 second. Started Nov 2004; status: completed.
02
Drugs
ipratropium bromidesalbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00096616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096616.